{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:48:03Z","timestamp":1794718083966,"version":"4.9.1"},"reference-count":40,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>We aim to search for predictors of survival among clinical and brain <jats:sup>18<\/jats:sup>F-FDG positron emission tomography (PET) metabolic features in our cohort of patients with multiple system atrophy (MSA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included patients with a \u2018probable\u2019 MSA diagnosis for whom a clinical evaluation and a brain PET were performed early in the course of the disease (median 3 years, IQR 2\u20135). A retrospective analysis was conducted using standardised data collection. Brain PET metabolism was characterised using the Automated Anatomical Labelling Atlas. A Cox model was applied to look for factors influencing survival. Kaplan-Meier method estimated the survival rate. We proposed to develop a predictive \u2018risk score\u2019, categorised into low-risk and high-risk groups, using significant variables entered in multivariate Cox regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighty-five patients were included. The overall median survival was 8\u2009years (CI 6.64 to 9.36). Poor prognostic factors were orthostatic hypotension (HR=6.04 (CI 1.58 to 23.12), p=0.009), stridor (HR=3.41 (CI 1.31 to 8.87), p=0.012) and glucose PET hypometabolism in the left insula (HR=0.78 (CI 0.66 to 0.92), p=0.004). Good prognostic factors were time to diagnosis (HR=0.68 (CI 0.54 to 0.86), p=0.001) and use of selective serotonin reuptake inhibitor (SSRI) (HR=0.17 (CI 0.06 to 0.46), p&lt;0.001). The risk score revealed a 5-year gap separating the median survival of the two groups obtained (5 years vs 10\u2009years; HR=5.82 (CI 2.94 to 11.49), p&lt;0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The clinical prognosis factors we have described support published studies. Here, we also suggest that brain PET is of interest for prognosis assessment and in particular in the search for left insula hypometabolism. Moreover, SSRIs are a potential drug candidate to slow the progression of the disease.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2020-324823","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T17:36:32Z","timestamp":1619199392000},"page":"881-889","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Early atypical signs and insula hypometabolism predict survival in multiple system atrophy"],"prefix":"10.1136","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0849-8213","authenticated-orcid":false,"given":"Stephan","family":"Grimaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Boucekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Witjas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Fluchere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Azulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Eusebio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"2022033001500914000_92.8.881.1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrneurol.2017.26","article-title":"Multiple system atrophy: insights into a rare and debilitating movement disorder","volume":"13","author":"Krismer","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"2022033001500914000_92.8.881.2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(89)90219-0"},{"key":"2022033001500914000_92.8.881.3","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000324625.00404.15"},{"key":"2022033001500914000_92.8.881.4","doi-asserted-by":"crossref","unstructured":"Schottlaender LV , Sailer A , Ahmed Z . Multiple System Atrophy: Clinical, Genetics, and Neuropathology [Internet]. In: Schapira A , Wszolek Z , Dawson TM , et al , eds. Neurodegeneration. Oxford, UK: John Wiley & Sons, Ltd, 2017: 58\u201371.","DOI":"10.1002\/9781118661895.ch7"},{"key":"2022033001500914000_92.8.881.5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314956"},{"key":"2022033001500914000_92.8.881.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2006.04.002"},{"key":"2022033001500914000_92.8.881.7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/mds.24983","article-title":"Maintaining glottic opening in multiple system atrophy: efficacy of serotonergic therapy","volume":"27","author":"Ozawa","year":"2012","journal-title":"Mov Disord"},{"key":"2022033001500914000_92.8.881.8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.parkreldis.2017.12.011","article-title":"Do selective serotonin reuptake inhibitors improve survival in multiple system atrophy?","volume":"48","author":"Coon","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"2022033001500914000_92.8.881.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.159822"},{"key":"2022033001500914000_92.8.881.10","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1995.00540260085021"},{"key":"2022033001500914000_92.8.881.11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2019.09.005","article-title":"Multiple system atrophy: phenotypic spectrum approach coupled with brain 18-FDG PET","volume":"67","author":"Grimaldi","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"2022033001500914000_92.8.881.12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1212\/WNL.0000000000008208","article-title":"Stridor in multiple system atrophy: consensus statement on diagnosis, prognosis, and treatment","volume":"93","author":"Cortelli","year":"2019","journal-title":"Neurology"},{"key":"2022033001500914000_92.8.881.13","unstructured":"Grimaldi S , Renaud M , Robert D . Prevalence and characterisation of vocal fold motion impairment (VFMI) in patients with Multiple system atrophy compared with Parkinson\u2019s disease [Internet]. Revue Neurologique, 2020. Available: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378720303817 [Accessed 30 May 2020]."},{"key":"2022033001500914000_92.8.881.14","unstructured":"Mattis S . Dementia rating scale. Odessa, FL: Psychological Assessment Resources, 1988."},{"key":"2022033001500914000_92.8.881.15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.11.1621"},{"key":"2022033001500914000_92.8.881.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2008.11.016"},{"key":"2022033001500914000_92.8.881.17","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.2001.0978"},{"key":"2022033001500914000_92.8.881.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104813","article-title":"Disease progression and prognostic factors in multiple system atrophy: a prospective cohort study","volume":"139","author":"Foubert-Samier","year":"2020","journal-title":"Neurobiol Dis"},{"key":"2022033001500914000_92.8.881.19","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25115"},{"key":"2022033001500914000_92.8.881.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2012.01.008"},{"key":"2022033001500914000_92.8.881.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2011.07933.x"},{"key":"2022033001500914000_92.8.881.22","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/S1353-8020(11)70066-9","article-title":"Fluoxetine protects neurons against microglial activation-mediated neurotoxicity","volume":"18 Suppl 1","author":"Zhang","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"2022033001500914000_92.8.881.23","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11055-019-00841-w","article-title":"Analysis of the pathways of the influences of the dorsal raphe nucleus on the basal ganglia based on the topography of the projections between them","volume":"49","author":"Gorbachevskaya","year":"2019","journal-title":"Neurosci Behav Physiol"},{"key":"2022033001500914000_92.8.881.24","doi-asserted-by":"crossref","unstructured":"Oostland M , van Hooft JA , et al . Serotonin in the Cerebellum. In: Gruol DL , Koibuchi N , Manto M , eds. Essentials of cerebellum and cerebellar disorders. Cham: Springer International Publishing, 2016: 243\u20137.","DOI":"10.1007\/978-3-319-24551-5_31"},{"key":"2022033001500914000_92.8.881.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2004.12.023"},{"key":"2022033001500914000_92.8.881.26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10286-018-0577-0","article-title":"Functional neuroimaging of the central autonomic network: recent developments and clinical implications","volume":"29","author":"Sklerov","year":"2019","journal-title":"Clin Auton Res"},{"key":"2022033001500914000_92.8.881.27","doi-asserted-by":"crossref","unstructured":"Benarroch E , Freeman R , Kaufmann H . Autonomic Nervous System. In: Textbook of clinical neurology. Elsevier, 2007: 383\u2013404.","DOI":"10.1016\/B978-141603618-0.10021-9"},{"key":"2022033001500914000_92.8.881.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2006.06.009"},{"key":"2022033001500914000_92.8.881.29","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.9.1727"},{"key":"2022033001500914000_92.8.881.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2008.08.004"},{"key":"2022033001500914000_92.8.881.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1509184113"},{"key":"2022033001500914000_92.8.881.32","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhl041"},{"key":"2022033001500914000_92.8.881.33","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-011-0136-4"},{"key":"2022033001500914000_92.8.881.34","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1002\/hbm.24548","article-title":"How the insula speaks to the heart: cardiac responses to insular stimulation in humans","volume":"40","author":"Chouchou","year":"2019","journal-title":"Hum Brain Mapp"},{"key":"2022033001500914000_92.8.881.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.68903.x"},{"key":"2022033001500914000_92.8.881.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.05.079"},{"key":"2022033001500914000_92.8.881.37","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001807"},{"key":"2022033001500914000_92.8.881.38","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/brain\/awz189","article-title":"Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study","volume":"142","author":"Miki","year":"2019","journal-title":"Brain"},{"key":"2022033001500914000_92.8.881.39","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22826"},{"key":"2022033001500914000_92.8.881.40","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3233\/JAD-180292","article-title":"Imaging Biomarkers of Neurodegeneration in Alzheimer\u2019s Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism","volume":"65","author":"Benvenutto","year":"2018","journal-title":"Journal of Alzheimer's Disease"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2020-324823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T08:52:39Z","timestamp":1648630359000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2020-324823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,7,16]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/jnnp-2020-324823"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2020-324823","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]}}}